Literature DB >> 19822391

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.

Ti Zhang1, Hui-Chuan Sun, Hong-Yuan Zhou, Jing-Tao Luo, Bai-Lin Zhang, Peng Wang, Lu Wang, Lun-Xiu Qin, Ning Ren, Sheng-Long Ye, Qiang Li, Zhao-You Tang.   

Abstract

The aim of this study was to observe the effect of interferon alpha (IFNalpha) on tumor endothelial cells (TECs) in highly metastatic hepatocellular carcinoma (HCC) model, and to investigate the underlying mechanism. Nude mice with HCC xenograft were treated with IFNalpha. Gene expression profiles of TECs were analyzed by utilizing cDNA microarray. The differentiation of tumor blood vessels was evaluated by CD31/alphaSMA dual immunohistochemistry. Apoptosis of TECs was determined by CD31/TUNEL double staining. The functions of TECs in adhesion and uptake of acetylated low-density lipoprotein were observed in vitro. Results showed that IFNalpha effectively inhibited HCC tumor growth, with decreased microvessel density, increased apoptosis in TECs and normalized tumor blood vessels. cDNA microarray analysis revealed differential gene expression patterns in TECs under the treatment of IFNalpha. The cell-cell contact distribution of VE-Cadherin and uptake of acetylated low-density lipoprotein were significantly inhibited by IFNalpha in cultivated TECs. These results suggest that IFNalpha may induce apoptosis and interfere with hemophilic adhesion of TECs. The changes of gene expression in TECs contribute essentially to its effect of anti-angiogenesis and the subsequent inhibition of tumor progression. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822391     DOI: 10.1016/j.canlet.2009.09.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.

Authors:  Peng-Yuan Zhuang; Ju-Bo Zhang; Wei Zhang; Xiao-Dong Zhu; Ying Liang; Hua-Xiang Xu; Yu-Quan Xiong; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang; Lun-Xiu Qin; Hui-Chuan Sun
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

Review 2.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

Review 3.  Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.

Authors:  Theofanis Floros; Ahmad A Tarhini
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

4.  Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.

Authors:  Kenji Ikeda; Yusuke Kawamura; Masahiro Kobayashi; Yoko Kominami; Shunichiro Fujiyama; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2017-09-07       Impact factor: 3.199

5.  Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.

Authors:  Norio Itokawa; Masanori Atsukawa; Akihito Tsubota; Tomomi Okubo; Taeang Arai; Ai Nakagawa; Chisa Kondo; Katsuhiko Iwakiri
Journal:  Int J Clin Oncol       Date:  2015-12-23       Impact factor: 3.402

6.  RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Authors:  Tiha M Long; Arindam Chakrabarti; Heather J Ezelle; Sarah E Brennan-Laun; Jean-Pierre Raufman; Irina Polyakova; Robert H Silverman; Bret A Hassel
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 7.  Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.

Authors:  Saad Shaaban; Amr Negm; Elsayed E Ibrahim; Ahmed A Elrazak
Journal:  Oncol Rev       Date:  2014-05-28

Review 8.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.

Authors:  Flávia Castro; Ana Patrícia Cardoso; Raquel Madeira Gonçalves; Karine Serre; Maria José Oliveira
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

9.  Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway.

Authors:  Jun Zhao; Ming-Li Wang; Zeng Li; Dong-Mei Gao; Yu Cai; Jun Chang; Shi-Ping Wang
Journal:  Cancer Biol Med       Date:  2014-03       Impact factor: 4.248

10.  Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells.

Authors:  Jun Zhao; Mingli Wang; Zeng Li; Jingxian Chen; Zongshen Yin; Jun Chang; Dongmei Gao; Shiping Wang
Journal:  Oncol Lett       Date:  2013-12-16       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.